Our lab studies how pathogens evolve and spread. We use experimental and computational tools to test our hypotheses and collaborate with clinical and public health institutions. Our overall aim is to improve diagnostics, therapeutics, and clinical and public health strategies to aid in the control of infectious diseases.
The United States is experiencing one of its most intense flu seasons in the past 25 years, with millions of illnesses, tens of thousands of hospitalizations, and thousands of deaths…
Antibiotic resistance is a mounting global crisis, as bacteria continue to evolve faster than existing medicines. A recent Harvard Gazette article highlights how scientists across Harvard are urgently seeking solutions to outpace these “superbugs,” developing new treatments and strategies to safeguard public health.
Gonorrhea bacteria are becoming more resistant to the antibiotic doxycycline, potentially because the drug is taken after unprotected sex to preemptively lower the chance of contracting other sexually transmitted infections, according to a study.
This summer the New England Journal of Medicine published a letter from our own David Helekal and Yonatan Grad, and lab alum Tatum Mortimer. The article, Expansion of tetM-Carrying Neisseria gonorrhoeae in the…
Yonatan Grad, professor of immunology and infectious diseases, comments on the potential impact of recent decisions related to vaccines made by Health and Human Services Secretary Robert F. Kennedy Jr.
